Search filters

List of works by Philipp Oster

A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants

scientific article published on 29 June 2018

Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers ⬇️

scientific article published on May 19, 2011

Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine

scientific article published on 7 April 2010

Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales

scientific article published on 16 September 2009

Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic

scientific article

Comparison and Correlation of Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac

scientific article published in 2007

Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac

scientific article

Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults

scientific article published on 01 July 2011

From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease

scientific article published in March 2005

Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines

scientific article

Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine

scientific article published in May 2009

Immunogenicity of 2 Investigational Serogroup B Meningococcal Vaccines in the First Year of Life

scientific article published on 01 November 2010

Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.

scientific article

Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.

scientific article published in July 2003

Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay

scientific article published on 7 March 2007

Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine

scientific article

MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain

scientific article published on 01 March 2005

Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus

scientific article published on 21 May 2010

Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine

scientific article published on 20 August 2014

Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B

scientific article published on 01 September 2008

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

scientific article

New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine in Children Aged 16???24 Months

article

Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine

scientific article

Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006

scientific article published on 18 May 2007

Proceedings of the Meningococcal Vaccine Strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New Zealand

scientific article

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

scientific article

Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW-D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea

scientific article published on 24 February 2016

Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study

scientific article published on 03 December 2020

Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children

scientific article published in August 2002

Safety and immunogenicity of two doses of quadrivalent meningococcal conjugate vaccine or one dose of meningococcal group C conjugate vaccine, both administered concomitantly with routine immunization to 12- to 18-month-old children

scientific article published on July 2014

The Global Meningitis Genome Partnership

scientific article published on 29 June 2020

The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic

scientific article published on 20 August 2004

The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease

scientific article published on 01 March 2005

The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans ⬇️

scientific article published on 01 June 2011

The strategy to control New Zealand's epidemic of group B meningococcal disease

scientific article

Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany

scientific article published in March 2010

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future

scientific article published on 07 March 2013

Paulina is supported by:

About Paulina

Help